Diego Centonze

Board of Experts

University of Rome Tor Vergata
Rome, Italy

Diego Centonze is Full Professor of Neurology at the Department of Systems Medicine of the University of Rome Tor Vergata and Director of the Unit of Neurology at the IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (IS), Italy. He also leads the Synaptic Immunopathology Laboratory at Tor Vergata University. His major clinical interest involves the evaluation of new drugs for the treatment of MS. His research interests are related to the role of inflammatory neurodegeneration and synaptic damage in the pathophysiology of Multiple Sclerosis and of its experimental mouse model (EAE).

He is Principal Investigator of many phase II, III and IV national and international trials with new therapeutic agents for MS, AD, PD, narcolepsy, HD, and member of advisory boards of Pharmaceutical Industries for treatment optimization in Multiple Sclerosis. Member of the Society for Neuroscience (SfN), of the Italian Neurological Society (SIN), of the Italian Neuroscience Society (SINS), of the Italian Neuroimmunonology Association (AINI) Council, of the Medical Academy of Rome, of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Prof. Centonze is author of around 400 peer-reviewed papers published in international journals of Neuroscience, Neurology and Psychiatry.